with identified genes, providing potential targets for drug discovery or drug repositioning (De Jong et al., 2016). The most recent phase of the PGC proposes pathway analyses that integrate data from GWAS findings with information about potential druggable targets to advance the pipeline from gene identification to drug discovery (Sullivan et al., 2017). The official PGC twitter account (@PGCgenetics) recently tweeted “PGC goal: Find genetic risk factors to go beyond to: reveal fundamental biology, inform clinical practice, id new therapeutic targets”.
